Evidence map›Paper›PMID 39912719›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025

Associations between Parity, History of Breastfeeding, and T-cell Profile of Ovarian Tumors.

Jennifer M Mongiovi, Mary K Townsend, Allison F Vitonis, Holly R Harris, Jennifer A Doherty, Ana Babic, Jonathan L Hecht, T Rinda Soong, Linda Titus, Jose R Conejo-Garcia and 4 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jennifer M MongioviDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0002-2083-8359
Mary K TownsendDivision of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University School of Medicine, Portland, Oregon.ORCID 0000-0003-2452-4477
Allison F VitonisDepartment of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-1243-0844
Holly R HarrisDivision of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0002-2572-6727
Jennifer A DohertyDepartment of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.ORCID 0000-0002-1454-8187
Ana BabicDepartment of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-1199-5958
Jonathan L HechtDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.ORCID 0000-0003-4771-2585
T Rinda SoongUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.ORCID 0000-0002-1565-992X
Linda TitusDepartment of Epidemiology, Dartmouth Geisel School of Medicine, Hanover, New Hampshire.ORCID 0000-0002-0599-3924
Jose R Conejo-GarciaDepartment of Integrative Immunobiology, Duke School of Medicine, Durham, North Carolina.ORCID 0000-0001-6431-4074
Brooke L FridleyDivision of Health Services and Outcomes Research, Children's Mercy Kansas City, Kansas City, Missouri.ORCID 0000-0001-7739-7956
Shelley S TworogerDivision of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University School of Medicine, Portland, Oregon.ORCID 0000-0002-6986-7046
Kathryn L TerryDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0009-0002-5848-4661
Naoko SasamotoDepartment of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-4526-2181

Funding

Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, TAMIMI, RULLA M · 2000 to 2019
$77.8M
Life Course Cancer Epidemiology Cohort in WomenU01CA176726 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI ELIASSEN, A. HEATHER, WILLETT, WALTER C. · 2018 to 2025
$22.4M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
Training Program in Cancer EpidemiologyT32CA009001 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI A. Heather Eliassen, Meir Stampfer · 1985 to 2026
$17.3M
Epidemiologic factors and survival by molecular subtypes of ovarian cancerR01CA168758 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DOHERTY, JENNIFER A., ROSSING, MARY ANNE · 2013 to 2016
$2.6M
Changing Contraceptive Patterns and Ovarian Cancer RiskR01CA258679 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI TERRY, KATHRYN L. · 2021 to 2025
$2.5M
Using biomarkers to elucidate the breastfeeding and ovarian cancer risk associationR03CA259659 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI SASAMOTO, NAOKO · 2022 to 2023
$179k
National Institutes of Health (NIH) R03CA259659NCI NIH HHS P01 CA087969NCI NIH HHS R01 CA168758NCI NIH HHS R01 CA258679NCI NIH HHS R03 CA259659NCI NIH HHS T32 CA009001NCI NIH HHS U01 CA176726NCI NIH HHS UM1 CA186107Rivkin Center for Ovarian Cancer (Rivkin Center)U.S. Department of Defense (DOD) W81XWH2110320
6 · The paper itself

Abstract

backgroundParity and breastfeeding are associated with systemic changes in maternal inflammation and reduced risk of ovarian cancer, but little is known about their impact on the ovarian tumor immune microenvironment.

methodsWe evaluated the associations of self-reported parity and history of breastfeeding with tumor-infiltrating T cells among 1,706 ovarian carcinoma cases with tumor tissue collected across four studies. The abundance of tumor-infiltrating T cells was measured by multiplex immunofluorescence in tumor tissue microarrays. ORs and 95% confidence intervals (CI) for the positivity of tumor immune cells were calculated using beta-binomial models and stratified by histotype.

resultsCompared with ovarian tumors in nulliparous women, there was no association between parity and ovarian tumor T-cell abundance among all histotypes combined but suggestion of increased cytotoxic T cells and T-cell exhaustion among parous women with clear-cell tumors. When restricted to parous women, history of breastfeeding was associated with increased odds for all T-cell types [i.e., total T, cytotoxic T, helper T (Th), regulatory T, and exhausted T cells], with ORs ranging from 1.11 to 1.42. For every 6 months of breastfeeding, we observed increased odds of activated Th-cell infiltration (CD3+CD4+CD69+; OR, 1.13, 95% CI, 0.99-1.29), with a similar association for high-grade serous tumors, but lower odds in clear-cell tumors (OR, 0.43, 95% CI, 0.21-0.87).

conclusionsHistory of breastfeeding may alter the ovarian tumor immune microenvironment by modulating the abundance of tumor-infiltrating T cells. IMPACT: Although replication is required, history of breastfeeding may play a role in the activation of the ovarian tumor immune response.

Indexed as

Breast FeedingLymphocytes, Tumor-InfiltratingOvarian NeoplasmsParityT-LymphocytesAdultAgedFemaleHumansMiddle AgedPregnancyTumor Microenvironment

Identifiers

PMID39912719
PMCPMC11968234

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.